- World rank, all time
- #26,778 of 42,892
- Rank in Estonia
- #14 of 24
- Research works
- 183 ▲ 37% vs 2013–17
- Citations
- 2.9k 15.8 per fractional work
- Top-10% rate
- 15.2% record average 16.5%
- Open access
- 47% world 28%
What is East Tallinn Central Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #11,488 of 17,978 | 11.3% | 120 | |
| Health SciencesDomain | #13,901 of 20,462 | 12.1% | 132 |
Each strip is that field’s whole ranked pool, with the notch where East Tallinn Central Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.3×. Every wedge is a field page.
- Medicine 3.3×
- Decision Sciences 2.3×
- Immunology and Microbiology 2.3×
- Health Professions 2.0×
- Veterinary 1.4×
- Neuroscience 1.3×
- Computer Science 1.1×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Nursing 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.7×
- Psychology 0.7×
- Business, Management and Accounting 0.6×
- Economics, Econometrics and Finance 0.5×
- Energy 0.4×
- Engineering 0.3×
- Physics and Astronomy 0.2×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Mathematics 0.1×
- Chemistry 0.0×
Which keywords describe research at East Tallinn Central Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Chemotherapy, Inflammation, Autoantibodies, Health-related Quality of Life, Metastasis, Clinical Guidelines and Functional Recovery.
- Uterine Fibroids
- Toll-like Receptors
- Ovarian Cancer
- Hydatidiform Mole
- Gestational Trophoblastic Disease
- Reproductive Outcome
- Data Integration
- Quality of Life
- Motor Recovery
- Deep Learning
- Complications
- Big Data
- Healthcare
- Oxidative Stress
- Health-related Quality of Life
- Autoantibodies
- Inflammation
- Epidemiology
- Chemotherapy
- Risk Factors
- Machine Learning
- Clinical Trials
- Metastasis
- Biomarkers
- Clinical Guidelines
- Functional Recovery
- Neural Plasticity
- Security
- Prenatal Diagnosis
- Genomic Analysis
- Global Burden
- Hysteroscopic Treatment
- Supply Chain Management
- Uterine Anomalies
- Uterine Leiomyoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 35 words, with their numbers
- Epidemiology6▲ 3.2×38 topics
- Inflammation3▲ 2.9×13 topics
- Chemotherapy2▲ 7.4×6 topics
- Autoantibodies2▲ 16×7 topics
- Risk Factors2▲ 3.4×6 topics
- Health-related Quality of Life2▲ 14×2 topics
- Machine Learning2◆ 1.08×8 topics
- Oxidative Stress2▲ 2.2×6 topics
- Clinical Trials1▲ 4.9×7 topics
- Healthcare1▲ 2.8×5 topics
- Metastasis1▲ 9.3×2 topics
- Big Data1▲ 3.3×4 topics
- Biomarkers1▲ 4.3×4 topics
- Complications1▲ 5.9×7 topics
- Clinical Guidelines1▲ 9.9×4 topics
- Deep Learning1▼ 0.81×4 topics
- Functional Recovery1▲ 19×2 topics
- Motor Recovery1▲ 34×1 topic
- Neural Plasticity1▲ 15×1 topic
- Quality of Life1▲ 1.98×11 topics
- Security1▲ 4.2×3 topics
- Data Integration1▲ 15×3 topics
- Prenatal Diagnosis1▲ 18×3 topics
- Reproductive Outcome1▲ 67×2 topics
- Genomic Analysis1▲ 9.6×1 topic
- Gestational Trophoblastic Disease1▲ 285×1 topic
- Global Burden1▲ 4.5×4 topics
- Hydatidiform Mole1▲ 285×1 topic
- Hysteroscopic Treatment1▲ 103×1 topic
- Ovarian Cancer1▲ 27×1 topic
- Supply Chain Management1▲ 2.5×2 topics
- Toll-like Receptors1▲ 22×2 topics
- Uterine Anomalies1▲ 103×1 topic
- Uterine Fibroids1▲ 78×1 topic
- Uterine Leiomyoma1▲ 78×1 topic
Which research topics does East Tallinn Central Hospital publish most on?
By volume in 2022–2025: Stroke Rehabilitation and Recovery, Gynecological conditions and treatments, Uterine Myomas and Treatments and Gestational Trophoblastic Disease Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Stroke Rehabilitation and Recovery Rehabilitation 1 works
- 2 Gynecological conditions and treatments Obstetrics and Gynecology 1 works
- 3 Uterine Myomas and Treatments Obstetrics and Gynecology 1 works
- 4 Gestational Trophoblastic Disease Studies Public Health, Environmental and Occupational Health 1 works
- 5 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
- 6 Blockchain Technology Applications and Security Information Systems 1 works
- 7 Data Quality and Management Management Science and Operations Research 1 works
- 8 Electronic Health Records Systems Health Information Management 1 works
- 9 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 10 Surgical site infection prevention Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has East Tallinn Central Hospital's research output changed?
Output in 2018–2022 was 37% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tallinn
- Tallinn University of Technology
- Praxis
- Tallinn University
- Estonian Academy of Sciences
- National Institute of Chemical Physics and Biophysics
- Ministry of Agriculture
- Institute of the Estonian Language
- Estonian Business School
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.